Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
05.01.26
/
50%
€20.00
Target price
05.01.27
€44.47
Performance (%)
1.00%
Price
05.02.26
€20.80
Summary
This prediction is currently active. Translation missing: en.rating_summary.performance.running.buy.can_not_happen This prediction currently runs until 05.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% |
| iShares Core DAX® | -0.197% | -1.724% |
| iShares Nasdaq 100 | -3.612% | -3.768% |
| iShares Nikkei 225® | 1.176% | 2.165% |
| iShares S&P 500 | -0.825% | -1.916% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Guggenheim from $64.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-35.00%
05.02.26
05.02.26
